Novel TYK2 Inhibitors with an N-(Methyl-d 3)pyridazine-3-carboxamide Skeleton for the Treatment of Autoimmune Diseases.
Liu F, Wang B, Liu Y, Shi W, Tang X, Wang X, Hu Z, Zhang Y, Guo Y, Chang X, He X, Xu H, He Y.
Liu F, et al. Among authors: wang x, wang b.
ACS Med Chem Lett. 2022 Oct 6;13(11):1730-1738. doi: 10.1021/acsmedchemlett.2c00334. eCollection 2022 Nov 10.
ACS Med Chem Lett. 2022.
PMID: 36385928
Free PMC article.